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Human S100A7 (psoriasin) is highly expressed in psoriasis and other inflammatory diseases; however, the function of S100A7 in
wound repair remains largely unknown. Here we demonstrated that skin injury increased the expression of S100A7. Damaged
cells from wounded skin induced the expression of S100A7 via the activation of Toll-like receptor 3 (TLR3) followed by the
activation of p38 MAPK. S100A7, in turn, acted on keratinocytes to induce the expression of terminal differentiation marker gene
loricrin through the activation of p38 MAPK and caspase-1. The differentiation of keratinocytes induced by S100A7 resulted in
skin stratification, thus efficiently promoting wound closure. Taken together, our results demonstrate that the activation of TLR3
accelerates wound closure via the induction of S100A7 to induce keratinocyte differentiation. These findings also provide new
insights into the development of different forms of treatment with skin wounds.
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INTRODUCTION
An efficient re-epithelialization is required for wound re-
pair (Eckert et al., 2002). In the skin, re-epithelialization
is accomplished by keratinocyte proliferation, migration,
stratification, and differentiation (Laplante et al., 2001; Li et
al., 2014). Among these, the proliferation and differentiation
of keratinocytes enable skin stratification, thus promoting
wound closure and forming a physical barrier (Lee et al.,
2006). Multiple factors are involved in the regulation of ker-
atinocyte proliferation and differentiation, including calcium,
epidermal growth factor and tumor necrosis factor (Jost et al.,
2001). Although the activation of Toll-like receptors (TLRs)
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such as TLR3 and TLR4 has been shown to play critical
roles in the response to tissue injury and subsequent tissue
repair and regeneration (Larsen et al., 2007; Rakoff-Nahoum
and Medzhitov, 2008; Chen et al., 2010, 2013), whether TLR
activation would regulate these factors to induce keratinocyte
differentiation after skin injury remains largely unknown.
Many genes encoding structural and regulatory proteins
are critical for keratinocyte proliferation and differentiation.
S100A family proteins that are characterized by two calcium-
binding sites are one of them. The gene of S100A family
is located on chromosome 1q21 which encodes many ker-
atinocyte differentiation-related proteins such as involucrin,
filaggrin and trichoyalin (Eckert et al., 2004). It has been
shown that the expression of S100A8 and S100A9 is strongly
induced within the first week after epidermal injury. The in-
creased expression of S100A8 and S100A9 in wound-associ-
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ated keratinocytes is related to the formation of hyper-thick-
ened epithelium (Thorey et al., 2001). Besides S100A8 and
S100A9, S100A7 has been shown to enhance the expression
of several differentiation marker genes in normal human ker-
atinocytes (Hattori et al., 2014). All these suggest that S100A
family proteins may induce epidermal keratinocyte differen-
tiation during wound healing.
Recently it has been reported that the topical application of
TLR2 agonist, macrophage-activating lipopeptide-2, acceler-
ates wound healing in diabetic murine skin wounds (Deiters,
2004). In addition to TLR2, the activation of TLR3 by appli-
cation of its agonist polyinosinic:polycytidylic acid (polyI:C)
improves wound repair (Lin, 2012). Both of these two lig-
ands promote wound healing via recruiting leukocytes to the
wounds. However, whether activation of TLR3 would regu-
late S100A family proteins to induce keratinocyte differenti-
ation is unclear.
Given the importance of TLR3 in the regulation of wound
healing and the potential role of S100A7 in keratinocyte
differentiation during skin stratification, we hypothesized
that TLR3 activation may induce S100A7 to regulate ker-
atinocyte differentiation for wound closure. In this study we
showed that TLR3 activation induced S100A7 expression in
keratinocytes, and further delineated a new mechanism by
which TLR3 regulated wound repair.
RESULTS
Skin injury increases the expression of S100A7
S100A7 has been reported as an antibacterial agent on the
skin surface; however, whether it would be involved in
wound re-epithelialization during wound repair remains
largely unknown. To address this question, full-thickness
incisions were made on the dorsal skin of C57BL/6 wild-type
mice as previously reported (Lai et al., 2012) and the ex-
pression of S100A7 was examined at day 3. Quantitative
real-time PCR (qPCR) showed that S100A7 mRNA expres-
sion was markedly increased in skin wounds compared to
normal skin (Figure 1A). Consistent with increased mRNA,
the protein abundance of S100A7 was dramatically increased
in skin wounds by western blot analysis (Figure 1B). In addi-
tion to the wounded skin, S100A7 expression was increased
in the burned skin of mice compared to normal skin (Figure
1C). Altogether, these results demonstrate that skin injury
increases S100A7 expression.
Damaged cells fromwounds activate TLR3-p38MAPK to
induce S100A7 expression in keratinocytes
To determine what factor induces S100A7 expression after
skin injury, the supernatants of normal and wounded skin ho-
mogenates were collected for keratinocyte stimulation as pre-
viously reported (Lai et al., 2012). Both supernatants from
normal and wounded-skin homogenates induced the expres-
sion of S100A7 in murine epidermal keratinocytes (Figure
2A). Specifically, S100A7 expression induced by the super-
natant from wounded-skin homogenate was higher than that
induced by normal skin homogenate (Figure 2A). These data
suggest that components from damaged tissue have higher
potentials to induce S100A7 expression in keratinocytes.
In skin injury, tissue damage results in the rapid generation
of abundant amounts of damaged cells, including necrotic
cells and apoptotic keratinocytes. To test whether damaged
keratinocytes could induce S100A7 expression in adjacent
normal cells, cultured keratinocytes were irradiated by ul-
traviolet B (UVB) to induce apoptosis and cell death (UVR-
cells). UVR-cells were then collected and added to stimulate
normal neonatal human epidermal keratinocytes (NHEKs).
S100A7 was significantly induced when normal NHEKs ex-
posed to UVR-cells but not when exposed to equal amounts
of dead, non-irradiated cells (Figure 2B).
Our previous observation has shown that damaged cells can
activate TLR3 to initiate inflammatory response after skin in-
Figure 1   Skin injury increases epidermal S100A7 expression. A, Quantification of S100A7 mRNA expression in day-3 skin wounds by quantitative real-time
PCR (qRCR). B, Immunoblot of S100A7 in skin extracts taken from 2 mm skin surrounding wound edges. C, Quantification of S100A7 mRNA expression of
burned skin in mice. ***, P<0.001. P values were determined by unpaired two-tailed t tests. Data are the means±SE and representative of three independent
experiments.
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Figure 2   Damaged cells from wounds and poly(I:C) activate TLR3-p38 MAPK to induce S100A7 in keratinocytes. A, Quantification of S100A7 mRNA
expression in murine keratinocytes stimulated by the supernatants of normal and wounded skin homogenates. 2 mm skin surrounding day-3 wound edges was
taken for homogenization. B, S100A7 mRNA expression in NHEKs induced by UVB-irradiated dead keratinocytes (UVR cells). C, Quantification of S100A7
mRNA expression in NHEKs induced by UVR cells before and after TLR3 was silenced. D, Immunoblot of S100A7 in NHEKs treated with 5 μg mL–1 poly(I:C)
by using S100A7-specific antibody. E, Quantification of S100A7 mRNA expression in NHEKs stimulated with TLR2 ligand (LTA), TLR4 ligand (LPS), TLR9
ligand (DNA), TLR3 liand (Poly(I:C)), TLR7 ligand (Imiquimod) and TLR5 ligand (Flagellin). F, Quantification of S100A7 mRNA expression in NHEKs
induced by poly(I:C) before and after TLR3 was silenced. G, Quantification of S100A7 mRNA expression in NHEKs treated with 5 μg mL–1 poly(I:C) in the
absence or presence of SB202190 (p38 MAPK inhibitor, 10 μmol L–1), SP600125 (JNK inhibitor, 15 μmol L–1) and PD98059 (ERK inhibitor, 10 μmol L–1). H,
Immunoblot of phospho-p38 MAPK in NHEKs treated with 5 μg mL–1 poly(I:C) at different time points. I, Immunoblot of S100A7 and phospho-p38 MAPK in
NHEKs treated with 5 μg mL–1 poly(I:C) with or without SB202190 for 1 h. ***, P<0.001. P values were analyzed by unpaired two-tailed t tests (B), one-way
ANOVA (A, C, E and F ) and two-way ANOVA (G). Data are the means±SE and representative of two independent experiments.
jury (Lai et al., 2009). To evaluate whether the activation of
TLR3 would be also required for S100A7 expression after
skin injury, we checked the expression of S100A7 in NHEKs
after TLR3 was silenced. TLR3 silencing significantly de-
creased the expression of S100A7 induced by UVR-cells in
NHEKs (Figure 2C). Moreover, TLR3 ligand, poly(I:C), in-
duced the expression of S100A7 in keratinocytes (Figure 2D,
2E and Figure S1A in Supporting Information) but not in
macrophages and fibroblasts (Figure S1B in Supporting In-
formation). Other TLR ligands such as LTA, LPS, DNA,
imiquimod and flagellin did not induce S100A7 expression
or had a minimal effect on the induction of S100A7 in ker-
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atinocytes (Figure 2E). Furthermore, the induction of S100A7
by poly(I:C) was dependent on the activation of TLR3 as si-
lencing TLR3 by siRNA significantly inhibited poly(I:C)-in-
duced S100A7 expression (Figure 2F).
To further determine TLR3-mediated downstream signal-
ing pathway, we used multiple inhibitors to treat NHEK in
the presence or absence of poly(I:C). Among these inhibitors,
only p38mitogen-activated protein kinase (MAPK) inhibitor,
SB202190, inhibited poly(I:C)-induced S100A7 expression
(Figure 2G and data not shown). In addition, poly(I:C) in-
duced the phosphorylation of p38 MAPK in a time-depen-
dent manner (Figure 2H) and this induction was inhibited by
p38 MAPK inhibitor SB202190 (Figure 2I). Consistent with
this, the expression of S100A7 induced by poly(I:C) was also
inhibited by p38 MAPK inhibitor (Figure 2I). All these data
demonstrate that the expression of S100A7 is dependent on
the activation of TLR3-p38 MAPK signaling pathway in ker-
atinocytes.
Poly(I:C) and S100A7 induce keratinocyte differentiation
Next we determined the function of poly(I:C) and S100A7 in
keratinocytes. We observed that poly(I:C) changed the mor-
phology of keratinocytes to differentiated status (Figure S1C
in Supporting Information) . Consistent with this, poly(I:C)
significantly induced the expression of the terminal differen-
tiation marker gene loricrin (LOR), but not other differentia-
tion genes such as filaggrin (FLG) and involucrin (IVL), in a
time-dependent manner in keratinocytes (Figure 3A). In ad-
dition to mRNA, poly(I:C) induced the production of loricrin
protein in keratinocytes (Figure 3B).
Since TLR3 ligand poly(I:C) was observed to induce
S100A7 expression, we hypothesized that the induction of
loricrin by poly(I:C) might be via S100A7. To test this, we
first stimulated keratinocytes with S100A7 and then evalu-
ated the expression of loricrin. Similar to poly(I:C), S100A7
significantly induced the expression of loricrin mRNA in
keratinocytes (Figure 3C and Figure S2A in Supporting
Information). In line with the increased mRNA expression,
loricrin protein was increased in keratinocytes stimulated
by S100A7 (Figure 3D). Moreover, the induction of loricrin
by poly(I:C) was dependent on the expression of S100A7
as silencing S100A7 markedly decreased poly(I:C)-induced
loricrin (Figure 3E). Taken together, these data demonstrate
that S100A7 induced by poly(I:C) increases the expression
Figure 3   Poly(I:C) and S100A7 induce loricrin expression in keratinocytes. A, Quantification of LOR, FLG and IVL mRNA expression in NHEKs stimulated
by 5 μg mL–1 poly(I:C) for different times. B, Immunoblot of loricrin protein production in NHEKs treated with 5 μg mL–1 poly(I:C) for 24 h. C, Quantification
of LOR, FLG and IVL mRNA expression in NHEKs stimulated by 30 ng mL–1 S100A7 for different times. D, Immunoblot of loricrin protein production
in NHEKs treated with 30 ng mL–1 S100A7 for 24 h. E, Immunoblot of loricrin in NHEKs treated with poly(I:C) (5 μg mL–1) before and after S100A7 was
silencing. ***, P<0.001. P-values were determined by two-way ANOVA. Data are the means±SE and representative of two independent experiments.
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of terminal differentiation gene loricrin, resulting in cell dif-
ferentiation.
S100A7 activates p38MAPKand caspase-1 to induce lori-
crin
Having known that S100A7 can induce loricrin expression
in keratinocytes, we next explored the mechanism by which
S100A7 induced loricrin. After the screening, we also found
that p38 MAPK inhibitor SB202190, but not other MAPK
inhibitors, markedly inhibited S100A7-indued p38 MAPK
phosphorylation and loricrin expression (Figure S2B in Sup-
porting Information, Figure 4A and B). As an inducer of
S100A7, poly(I:C) also induced loricrin expression and this
induction was inhibited by p38 MAPK inhibitor (Figure 4C
and Figure S2C in Supporting Information). In addition to
p38 MAPK, S100A7 induced the expression of caspase-1 in
a time-dependent manner (Figure 4D and Figure S2D in Sup-
porting Information). The induction of caspase-1 by S100A7
was dependent on the activation of p38 MAPK as the inhi-
bition of p38 MAPK blocked the production of S100A7-in-
duced caspase-1 (Figure 4A).Moreover, the activation of cas-
pase-1 was required for poly(I:C) and S100A7 to induce the
expression of loricrin as the inhibition of caspase-1 activity
by its inhibitor abrogated the effect of poly(I:C) and S100A7
on the induction of loricrin (Figure 4E, F and Figure S2E in
Supporting Information). Furthermore, the induction of cas-
pase-1 by poly(I:C) was dependent on S100A7 as silencing
S100A7 by shRNA blocked the expression of caspase-1 in-
duced by poly(I:C) (Figure 4G and Figure S2F in Support-
ing Information). Taken together, these data demonstrate that
S100A7 induces loricrin expression via the activation of p38
MAPK and Caspase-1.
S100A7 accelerates wound closure
Having established the involvement of S100A7 in the regula-
tion of keratinocyte differentiation, we next set out to deter-
mine the physiological relevance of S100A7 during wound
healing. It is known that keratinocyte differentiation leads
Figure 4    S100A7 activates p38 MAPK and caspase-1 to induce loricrin. A, Immunoblot of phospho-p38 MAPK and caspase-1 in NHEKs treated with
S100A7 (30 ng mL–1) in the presence or absence of SB202190 (10 μmol L–1) for 2 h. B and C, Immunoblot of loricrin in NHEKs treated with S100A7 (30
ng mL–1) or poly(I:C) (5 μg mL–1) with or without SB202190 (10 μmol L–1) for 24 h. D, Immunoblot of caspase-1 in NHEKs treated with S100A7 (30 ng
mL–1) for different times. E and F, Immunoblot of loricrin and caspase-1 in NHEKs treated with poly(I:C) (5 μg mL–1) or S100A7 (30 ng mL–1) with or without
caspase-1 inhibitor I (20 μmol L–1). G, Immunoblot of caspase-1 in NHEKs treated with poly(I:C) (5 μg mL–1) before and after S100A7 was silenced. Data are
representative of two independent experiments.
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to skin stratification and the appropriate stratification is re-
quired for wound closure (Laplante et al., 2001). We thereby
hypothesized that S100A7 might be involved in skin stratifi-
cation during wound repair. To test this, 500 ng S100A7 was
intradermally injected into mouse dorsal skin before wound-
ing. The application of S100A7 significantly increased epi-
dermal stratification, re-epithelialization in a time-dependent
manner compared to control mice (Figure 5A), thus accel-
erating wound healing (Figure 5B and C). Consistently, the
expression of loricrin was increased in day-7 skin wounds ac-
companied with quicker epidermal stratification (Figure 5D).
All these data demonstrate that S100A7 induces skin stratifi-
cation to accelerate wound closure.
DISCUSSION
After skin injury, re-epithelialization is one of the most essen-
tial part for wound repair, as the tissue’s primary objective is
to quickly reestablish barrier function (Martin, 1997; Epstein
et al., 1999). It is known that the proliferation, migration and
differentiation of epidermal keratinocytes are precisely
Figure 5    (Colour online) S100A7 accelerates wound closure in vivo. A, Immunofluorescent staining of skin wounds with or without S100A7 treatment at
indicated times by K14 and Loricrin antibodies. Long scale bar represents 500 μm, and short scale bar represents 50 μm. Squares designate region of 200×
magnification shown in inset. B, Photographs of healing wounds in mice intradermally injected with or without S100A7. C, Wound healing of mice treated
as in (A). D, Immunoblot of loricrin in skin wounds of mice treated with or without S100A7 at day 7. *, P<0.05; **, P<0.01; ***, P<0.001. P-values were
determined by two-way ANOVA. Data are the means±SE and representative of two independent experiments.
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controlled to ensure the successful wound re-epithelializa-
tion (Gurtner et al., 2008); however, whether the activation
of TLRs would be involved in this process was not clear.
Here we observed that TLR3 activation might regulate epi-
dermal repair through the induction of S100A7 to control
keratinocyte differentiation during wound repair. Our results
show that damaged cells from skin wounds activate TLR3
to induce S100A7 expression. S100A7, in turn, induces ker-
atinocytes differentiation by the activation of p38MAPK and
caspase-1, events that we show have a major role in promot-
ing skin stratification and wound re-epithelialization. Thus,
the identification of S100A7 as a stimulus for keratinocyte
differentiation, and the elucidation of its mechanism of ac-
tion, provides the crucial information for understanding epi-
dermal homeostasis and wound repair.
Recently Lin et al. has reported that topical application
with TLR3 ligand poly(I:C) markedly enhanced re-ep-
ithelialization, granulation and neovascularization, thus
promoting wound healing (Lin et al., 2012). They pointed
out that poly(I:C) exerted these functions by increasing
neutrophil and macrophage recruitment, which is consistent
with our previous observation in skin wounds (Lai et al.,
2009). However, wound re-epithelialization is accomplished
by keratinocyte proliferation, migration and differentiation,
not leukocyte recruitment. It thereby raised possibility
that poly(I:C) might regulate keratinocyte proliferation
and differentiation to promote re-epithelialization. Here
we confirmed this hypothesis and showed that stimulating
keratinocytes with poly(I:C) in vitro directly induced the
differentiation of keratinocytes, and this induction was de-
pendent on S100A7 expression, suggesting that poly(I:C)
promotes wound re-epithelialization via the induction of
S100A7.
TLR activation triggers inflammatory responses in injury
and trauma, thus either impairing or promoting the healing
process (Dasu and Rivkah Isseroff, 2012). For example,
wound healing in Tlr2–/– diabetic mice was markedly quicker
than that in wild-type diabetic mice (Dasu et al., 2010).
However, Deiters et al showed that the application of TLR2
agonist accelerates wound healing in diabetic mice (Deiters
et al., 2004). Moreover, the deficiency of TLR4 in normal
mice leads to impaired early stage skin wound closure due
to the decreased expression of IL-1β and IL-6 (Dasu and
Rivkah Isseroff, 2012; Chen et al., 2013). One may assume
that the timing of the activation of specific TLRs under spe-
cific circumstances may be a critical element in determining
whether the activation of TLRs impairs or improves wound
healing (Dasu and Rivkah Isseroff, 2012). Alternatively, the
route of presentation of TLR agonist (endogenous or ex-
ogenous ligands) and its access to cells bearing the receptor
would initiate different innate responses (Dasu and Rivkah
Isseroff, 2012). Furthermore, in sterile conditions TLRs are
activated by endogenous ligands such as hyaluronan and
double-stranded RNA that are released from necrotic cells
(Scaffidi et al., 2002; Jiang et al., 2005; Tian et al., 2007;
Lai et al., 2009). Whether these ligands initiate appropriate
inflammatory response to regulate keratinocyte proliferation
and differentiation for wound repair or induce excessive pro-
duction of inflammatory cytokines to impair wound healing
needs further investigation.
Multiple factors including all-trans retinoic acid, calcium
and UV have been reported to be involve in the induction
of S100A7 (Hoffmann et al., 1994; Zouboulis et al., 1996;
Eckert et al., 2004). However, which factors in skin wounds
would induce the expression of S100A7 was unclear. Our
previous observation has shown that skin injury increased the
expression of IL-17 and IL-22, and then IL-17 and IL-22 in-
duce S100A7 expression in keratinocytes (Nakajima et al.,
2011; Lai et al., 2012). Herewe show that damaged cells from
skin wounds activated TLR3 to directly induce S100A7 ex-
pression. Moreover, our previous study shows that damaged
cells also activate TLR3 to initiate inflammatory response af-
ter skin injury (Lai et al., 2009). Therefore, another possibil-
ity will be that damaged cells activate TLR3 to recruit IL-17-
or IL-22-producing cells to wounds and then release IL-17
and IL-22 to induce S100A7 expression.
It is well-known that calcium plays an important role in the
formation of the cornfield envelop and stratum corneum bar-
rier by inducing the terminal differentiation of keratinocytes
(Watt, 1989; Nemes et al., 1999). As calcium binding pro-
tein, S100A family proteins have been shown to be induced
by calcium and then regulate cell differentiation during tis-
sue remodeling and repair (Hoffmann et al., 1994; Voss et
al., 2011, 2012). However, the underlying mechanism was
not fully understood. Here we revealed that S100A7 that was
induced by dead cells around wounds regulated the terminal
differentiation marker gene loricrin expression, thus leading
to keratinocyte differentiation. The induction of loricrin by
S100A7 was via the activation of p38 MAPK, an important
factor involved in the differentiation of keratinocyte (Efimova
et al., 2003; Ivanova and Dagnino, 2007). Although previ-
ous reports have shown that the activation of caspase-3 and
caspase-14 led to normal loss of nuclei in differentiated ker-
atinocyte (Weil et al., 1999; Eckhart et al., 2000), here we
found that S100A7 activated caspase-1, but not caspase-3 and
caspase-14, to induce keratinocytes differentiation, suggest-
ing that a specific signal cascade is activated by S100A7 for
keratinocyte differentiation.
In conclusion, our findings suggest that the induction of
S100A7 by TLR3 activation in skin wounds is necessary for
wound closure. Specifically, we find that S100A7 exerts its
effect by inducing keratinocyte differentiation and skin strati-
fication via the activation of p38MAPK and caspase-1. These
findings reveal a new mechanism by which TLR3 activation
regulates wound repair, and provide a potential therapeutic
strategy for the treatment of skin wounds.
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MATERIALS AND METHODS
Reagents
Caspase-1 inhibitor I and antibodies including loricrin and
caspase-1 were purchased from Santa Cruz Biotechnology
(USA). Antibodies directed against phospho-p38 MAPK and
p38 MAPK were purchased from Cell Signaling Technology
(Beverly, USA). The antibody for S100A7 and soluble re-
combinant human S100A7 were purchased from Sino Bio-
logical Inc (Beijing). The antibody against β-actin and in-
hibitors including SB202190, SP600125 and PD98059 were
purchased from Sigma-Aldrich (USA). Poly(I:C) was pur-
chased from InvivoGen (France).
Mice
All mice (C57BL/6) were housed and bred in specific
pathogen-free conditions in the animal facilities of East
China Normal University. All animal experiments were
approved by East China Normal University Animal Care and
Use Committee.
Cutaneous injury in vivo
For incisional wounds, full-thickness incisions were made on
the dorsal skin of C57BL/6 wild-type mice by 8 mm biopsy
punches. For burned wounds, a 8 mm-diameter iron block
was preheated in boiling water for 10 min, and stuck to the
dorsal skin of mice for 5 s. 2 mm of skin around wound edges
or unwounded skin were taken at day 3 for protein extraction
and RNA isolation as described previously (Lai et al., 2012).
For S100A7 treatment, the dorsal skin of mice were intrader-
mally injected with 100 µL phosphate buffer saline (PBS) or
100 µL S100A7 (5 ng μL–1) for twice (6 and 24 h) before
full-thickness incisions. The wounds were photographed ev-
ery other days and the healing area was calculated by Image J.
Cell culture
Neonatal human epidermal keratinocytes (NHEKs) (Cas-
cade Biologics, USA) were cultured in serum-free EpiLife
medium (Cascade Biologics) containing 0.6 mmol L–1 Ca2+,
1× Epilife® defined growth supplement (EDGS), 50 U mL–1
penicillin, and 50 μg mL–1 streptomycin under standard
culture conditions.
shRNA preparation and siRNA
Oligonucleotides encoding human S100A7 (Table 1) were
designed and synthesized. Blast search was performed by
using the National Center for Biotechnology Information
(NCBI) database to ensure that the shRNA constructs were
targeting only human S100A7. The oligonucleotides which
contained Hpa I and Xho I restriction sites were annealed
and cloned into the pLL3.7 vector as the manufacturer de-
scribed. The detailed method was described as previously
reported (Lai et al., 2012). 3 pairs of siRNA targeting TLR3
were purchased from GenePharma (Table 2) company and
transfected into NHEK cells as the manufacturer described.
Quantitative real-time PCR
Total RNA was isolated from wounded or unwounded
mouse skin or cells by using RNAiso Plus (TaKaRa, Japan).
500 ng total RNA was used for reverse transcription by
PrimeScript® RT reagent Kit (TaKaRa). Quantitative
Real-time PCR was performed in a Stratagene Mx3005P
Multiplex Quantitative PCR System (Agilent Technologies,
USA). Quantitative real-time PCR specific primers as shown
in Table 3 were used to evaluate gene expression. The
comparative ∆∆CT method was used to determine the quan-
tification of gene expression. The target gene expression in
the test samples was normalized to the endogenous reference
GAPDH level and reported them as the fold difference
relative to GAPDH gene expression.
Immunoblot
2 mm skin taken from mouse wound edge 3 days after ase-
ptic injury or cells were lysed by using RIPA buffer (pH 7.4)
containing protease inhibitor cocktail (Roche, Switzerland),
Table 1    S100A7 shRNA oligonucleotides
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Table 2    TLR3 siRNA oligonucleotides
Forward (3′–5′) Reverse (3′–5′)
Negative control UUCUCCGAACGUGUCACGUTT ACGUGACACGUUCGGAGAATT
h-TLR3-1757 GUCCCAUUUAUUUCCUAAATT UUUAGGAAAUAAAUGGGACTT
h-TLR3-2025 GCGCUUUAAUCCCUUUGAUTT AUCAAAGGGAUUAAAGCGCTT
h-TLR3 -2658 GGAGAUUCCAGAUUAUAAATT UUUAUAAUCUGGAAUCUCCTT
Table 3    qPCR and RT-PCR primers










and then were sonicated on ice-cold water for 15 min. Pro-
tein concentrations of the extracts were measured by BCATM
Protein Assay Kit (Pierce, USA) and equal amount of total
protein from each sample was separated with sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and then transferred to nitrocellulose membrane followed by
probing with the indicated antibodies.
Immunofluorescence
5 µm paraffin-embedded tissue sections were dewaxed and
pretreated with antigen retrieval solution. The sections
were stained with the first antibodies (K14, Abcam; and
Loricrin, Abcam, UK) and the secondary antibodies (Alexa
Fluor 488 and 594 conjugate, Life Technologies, USA)
and then mounted in ProLong Gold antifade reagent with
4,6-diamidino-2-phenylindole (DAPI) (Invitrogen, USA).
Statistical analysis
All data are presents as mean±SE, and Student’s t-test was
used to assess the significant difference between two groups.
One-way or Two-way ANOVA was used for analyzing sig-
nificant difference of multiple groups. For all statistical tests,
we considered P<0.05 to be statistically significant.
Compliance and ethics     The author(s) declare that they have no conflict
of interest.
Acknowledgements    This work was supported by the National Nat-
ural Science Foundation of China (31170867, 31470878, 31222021,
81202327), the Science and Technology Commission of Shanghai Munic-
ipality (13JC1402301, 11DZ2260300), Shanghai Education Commission
(13SG25), and Henry Fok Educational Foundation (141017).
Chen, L., Arbieva, Z.H., Guo, S., Marucha, P.T., Mustoe, T.A., and DiPietro,
L.A. (2010). Positional differences in the wound transcriptome of skin
and oral mucosa. BMC Genomics 11, 471.
Chen, L., Guo, S., Ranzer, M.J., andDiPietro, L.A. (2013). Toll-like receptor
4 has an essential role in early skin wound healing. J Invest Dermatol
133, 258–267.
Dasu, M.R., and Rivkah Isseroff, R. (2012). Toll-like receptors in wound
healing: location, accessibility, and timing. J Invest Dermatol 132,
1955–1958.
Dasu, M.R., Thangappan, R.K., Bourgette, A., DiPietro, L.A., Isseroff,
R., and Jialal, I. (2010). TLR2 expression and signaling-dependent
inflammation impair wound healing in diabetic mice. Lab Invest 90,
1628–1636.
Deiters, U., Barsig, J., Tawil, B., and Muhlradt, P.F. (2004). The
macrophage-activating lipopeptide-2 accelerates wound healing in
diabetic mice. Exp Dermatol 13, 731–739.
Eckert, R.L., Broome, A.M., Ruse, M., Robinson, N., Ryan, D., and Lee, K.
(2004). S100 proteins in the epidermis. J Invest Dermatol 123, 23–33.
Eckert, R.L., Efimova, T., Dashti, S.R., Balasubramanian, S., Deucher, A.,
Crish, J.F., Sturniolo, M., and Bone, F. (2002). Keratinocyte survival,
differentiation, and death: many roads lead to mitogen-activated protein
kinase. J Invest Dermatol Sympos Proc 7, 36–40.
Eckhart, L., Declercq, W., Ban, J., Rendl, M., Lengauer, B., Mayer, C.,
Lippens, S., Vandenabeele, P., and Tschachler, E. (2000). Terminal dif-
ferentiation of human keratinocytes and stratum corneum formation is as-
sociated with caspase-14 activation. J Invest Dermatol 115, 1148–1151.
Efimova, T., Broome, A.M., and Eckert, R.L. (2003). A regulatory role for
p38  MAPK in keratinocyte differentiation: evidence for p38 -ERK1/2
complex formation. J Biol Chem 278, 34277–34285.
Gurtner, G.C., Werner, S., Barrandon, Y., and Longaker, M.T. (2008).
Wound repair and regeneration. Nature 453, 314–321.
Hattori, F., Kiatsurayanon, C., Okumura, K., Ogawa, H., Ikeda, S., Okamoto,
K., and Niyonsaba, F. (2014). The antimicrobial protein S100A7/psori-
asin enhances the expression of keratinocyte differentiation markers and
strengthens the skin’s tight junction barrier. Br J Dermatol 171, 742–753.
Hoffmann, H.J., Olsen, E., Etzerodt, M., Madsen, P., Thøgersen, H.C.,
Kruse, T., and Celis, J.E. (1994). Psoriasin binds calcium and is upregu-
lated by calcium to levels that resemble those observed in normal skin.
J Invest Dermatol 103, 370–375.
166 Lei, H., et al.   Sci China Life Sci   February (2017)  Vol. 60  No. 2
Ivanova, I.A., and Dagnino, L. (2007). Activation of p38- and CRM1-de-
pendent nuclear export promotes E2F1 degradation during keratinocyte
differentiation. Oncogene 26, 1147–1154.
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G.D.,
Mascarenhas, M.M., Garg, H.G., Quinn, D.A., Homer, R.J., Goldstein,
D.R., Bucala, R., Lee, P.J., Medzhitov, R., and Noble, P.W. (2005). Reg-
ulation of lung injury and repair by Toll-like receptors and hyaluronan.
Nat Med 11, 1173–1179.
Jost, M., Huggett, T.M., Kari, C., and Rodeck, U. (2001). Matrix-indepen-
dent survival of human keratinocytes through an EGF receptor/MAPK-
kinase-dependent pathway. Mol Biol Cell 12, 1519–1527.
Lai, Y., Di Nardo, A., Nakatsuji, T., Leichtle, A., Yang, Y., Cogen, A.L., Wu,
Z.R., Hooper, L.V., Schmidt, R.R., von Aulock, S., Radek, K.A., Huang,
C.M., Ryan, A.F., and Gallo, R.L. (2009). Commensal bacteria regulate
Toll-like receptor 3—dependent inflammation after skin injury. Nat Med
15, 1377–1382.
Lai, Y., Li, D., Li, C., Muehleisen, B., Radek, K.A., Park, H.J., Jiang, Z., Li,
Z., Lei, H., Quan, Y., Zhang, T., Wu, Y., Kotol, P., Morizane, S., Hata,
T.R., Iwatsuki, K., Tang, C., and Gallo, R.L. (2012). The antimicrobial
protein REG3A regulates keratinocyte proliferation and differentiation
after skin injury. Immunity 37, 74–84.
Laplante, A.F., Germain, L., Auger, F.A., and Moulin, V. (2001). Mecha-
nisms of wound reepithelialization: hints from a tissue-engineered re-
constructed skin to long-standing questions. FASEB J 15, 2377–2389.
Larsen, P.H., Holm, T.H., and Owens, T. (2007). Toll-like receptors in brain
development and homeostasis. Sci STKE 2007, pe47–pe47.
Lee, S.H., Jeong, S.K., and Ahn, S.K. (2006). An update of the defensive
barrier function of skin. Yonsei Med J 47, 293–306.
Li, M.R., Ti, D.D., Han, W.D., and Fu, X.B. (2014). Microenvironment-
induced myofibroblast-like conversion of engrafted keratinocytes. Sci
China Life Sci 57, 209–220.
Lin, Q., Wang, L., Lin, Y., Liu, X., Ren, X., Wen, S., Du, X., Lu, T., Su,
S.Y., Yang, X., Huang, W., Zhou, S., Wen, F., and Su, S.B. (2012). Toll-
like receptor 3 ligand polyinosinic: polycytidylic acid promotes wound
healing in human and murine skin. J Invest Dermatol 132, 2085–2092.
Martin, P. (1997). Wound healing—aiming for perfect skin regeneration.
Science 276, 75–81.
Nakajima, K., Kanda, T., Takaishi, M., Shiga, T., Miyoshi, K., Nakajima, H.,
Kamijima, R., Tarutani, M., Benson, J.M., Elloso, M.M., Gutshall, L.L.,
Naso, M.F., Iwakura, Y., DiGiovanni, J., and Sano, S. (2011). Distinct
roles of IL-23 and IL-17 in the development of psoriasis-like lesions in
a mouse model. J Immunol 186, 4481–4489.
Nemes, Z., Marekov, L.N., and Steinert, P.M. (1999). Involucrin cross-link-
ing by transglutaminase 1: binding to membranes directs residue speci-
ficity. J Biol Chem 274, 11013–11021.
Rakoff-Nahoum, S., and Medzhitov, R. (2008). Role of /oll-like receptors in
tissue repair and tumorigenesis. Biochem Moscow 73, 555–561.
Scaffidi, P., Misteli, T., and Bianchi, M.E. (2002). Release of chromatin
protein HMGB1 by necrotic cells triggers inflammation. Nature 418,
191–195.
Epstein, F.H., Singer, A.J., and Clark, R.A.F. (1999). Cutaneous wound heal-
ing. N Engl J Med 341, 738–746.
Thorey, I.S., Roth, J., Regenbogen, J., Halle, J.P., Bittner, M., Vogl, T.,
Kaesler, S., Bugnon, P., Reitmaier, B., Durka, S., Graf, A., Wockner,
M., Rieger, N., Konstantinow, A., Wolf, E., Goppelt, A., and Werner, S.
(2001). The Ca2+-binding proteins S100A8 and S100A9 are encoded by
novel injury-regulated genes. J Biol Chem 276, 35818–35825.
Tian, J., Avalos, A.M., Mao, S.Y., Chen, B., Senthil, K., Wu, H., Parroche,
P., Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L.L., Audoly, L., La
Rosa, G., Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow,M.K.,
Fitzgerald, K.A., Latz, E., Kiener, P.A., and Coyle, A.J. (2007). Toll-like
receptor 9-dependent activation by DNA-containing immune complexes
is mediated by HMGB1 and RAGE. Nat Immunol 8, 487–496.
Voss, A., Bode, G., Sopalla, C., Benedyk, M., Varga, G., Böhm, M., Nacken,
W., and Kerkhoff, C. (2011). Expression of S100A8/A9 in HaCaT ker-
atinocytes alters the rate of cell proliferation and differentiation. FEBS
Lett 585, 440–446.
Voss, A., Gescher, K., Hensel, A., Nacken, W., Zänker, K.S., and Kerkhoff,
C. (2012). Double-stranded RNA induces S100 gene expression by a
cycloheximide-sensitive factor. FEBS Lett 586, 196–203.
Watt, F.M. (1989). Terminal differentiation of epidermal keratinocytes. Curr
Opin Cell Biol 1, 1107–1115.
Weil, M., Raff, M.C., and Braga, V.M.M. (1999). Caspase activation in the
terminal differentiation of human epidermal keratinocytes. Curr Biol 9,
361–365.
Zouboulis, C.C., Voorhees, J.J., Orfanos, C.E., and Tavakkol, A. (1996).
Topical all-trans retinoic acid (RA) induces an early, coordinated
increase in RA-inducible skin-specific gene/psoriasin and cellular
RA-binding protein II mRNA levels which precedes skin erythema.
Arch Dermatol Res 288, 664–669.
SUPPORTING INFORMATION
Figure S1 Poly(I:C) induces keratinocyte differentiation and the expression of S100A7 in keratinocytes, but not in macrophages and fibroblasts.
Figure S2 S100A7 activates p38 MAPK and caspase-1 to induce loricrin.
The supporting information is available online at life.scichina.com and www.springerlink.com. The supporting materials are
published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely
with the authors.
Lei, H., et al.   Sci China Life Sci   February (2017)  Vol. 60  No. 2 167
